Drug Patent Expirations in January 2012

Drug Patent Expirations in January 2012

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
VITRASERT Bausch And Lomb ganciclovir 5,378,475 Jan 3, 2012
LUNESTA Sunovion Pharms Inc eszopiclone 6,319,926 Jan 16, 2012
LUNESTA Sunovion Pharms Inc eszopiclone 7,381,724 Jan 16, 2012
PREFEST Teva Womens estradiol; norgestimate 5,382,573 Jan 17, 2012
VIDEX Bristol Myers Squibb didanosine 5,880,106*PED Jan 22, 2012
OCTREOSCAN Mallinckrodt indium in-111 pentetreotide kit 5,384,113 Jan 24, 2012
TASMAR Valeant Pharm Intl tolcapone 5,236,952 Jan 29, 2012
PROTOPIC Astellas tacrolimus 5,385,907 Jan 31, 2012

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

Courtesy of DrugPatentWatch.com


Leave a Reply